| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43911 | |||
| BSA Free | NBP2-52952-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43979 | |||
| BSA Free | NBP2-52919-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74173 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81038-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-44913-0.02mg | |||
| Azide and BSA Free | NBP3-11559 | |||
![Western Blot: EGFR Antibody (CL0815) [NBP2-52952] - Lane 1: Marker [kDa], Lane 2: Human cell line A-431](http://images.novusbio.com/fullsize/EGFR-Antibody-CL0815-Western-Blot-NBP2-52952-img0004.jpg "Western Blot: EGFR Antibody (CL0815) [NBP2-52952] - Lane 1: Marker [kDa], Lane 2: Human cell line A-431")
![Immunohistochemistry-Paraffin: EGFR Antibody (CL0815) [NBP2-52952] - Staining of human ventricular cancer shows moderate membranous immunoreactivity in tumor cells.](http://images.novusbio.com/fullsize/EGFR-Antibody-CL0815-Immunohistochemistry-Paraffin-NBP2-52952-img0003.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (CL0815) [NBP2-52952] - Staining of human placenta shows strong membranous positivity in trophoblast.](http://images.novusbio.com/fullsize/EGFR-Antibody-CL0815-Immunohistochemistry-Paraffin-NBP2-52952-img0001.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (CL0815) [NBP2-52952] - Staining of human tonsil shows moderate membranous immunoreactivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/EGFR-Antibody-CL0815-Immunohistochemistry-Paraffin-NBP2-52952-img0002.jpg)
![Western Blot: CaM Kinase II alpha Antibody [NBP2-46796] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10, Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/CaM-Kinase-II-alpha-Antibody-Western-Blot-NBP2-46796-img0004.jpg "Western Blot: CaM Kinase II alpha Antibody [NBP2-46796] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10, Lane 2: Human cell line RT-4")
![Immunocytochemistry/Immunofluorescence: CaM Kinase II alpha Antibody [NBP2-46796] - Staining of human cell line U-2 OS shows localization to plasma membrane.](http://images.novusbio.com/fullsize/CaM-Kinase-II-alpha-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-46796-img0005.jpg)
![Immunohistochemistry-Paraffin: CaM Kinase II alpha Antibody [NBP2-46796] - Staining of human hippocampus shows moderate positivity in subsets of neuronal cells.](http://images.novusbio.com/fullsize/CaM-Kinase-II-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-46796-img0006.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0344-Immunohistochemistry-Paraffin-NBP2-52919-img0009.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0344-Immunohistochemistry-Paraffin-NBP2-52919-img0005.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining of human kidney shows strong cytoplasmic positivity in endothelial cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0344-Immunohistochemistry-Paraffin-NBP2-52919-img0006.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining of human small intestine shows strong cytoplasmic positivity in endothelial cells, as well as positivity in smooth muscle.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0344-Immunohistochemistry-Paraffin-NBP2-52919-img0007.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0344) [NBP2-52919] - Staining of human tonsil shows no cytoplasmic positivity in lymphoid cells as expected.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0344-Immunohistochemistry-Paraffin-NBP2-52919-img0008.jpg)
![Western Blot: PTPN11/SHP2 Antibody (3F2) [NBP2-03063] Analysis of extracts (35ug) from 9 different cell lines by using anti-PTPN11/SHP2 monoclonal antibody.](http://images.novusbio.com/fullsize/PTPN11-SHP2-Antibody-3F2-Western-Blot-NBP2-03063-img0004.jpg "Western Blot: PTPN11/SHP2 Antibody (3F2) [NBP2-03063] Analysis of extracts (35ug) from 9 different cell lines by using anti-PTPN11/SHP2 monoclonal antibody.")
![Flow Cytometry: PTPN11/SHP2 Antibody (3F2) [NBP2-03063] - Analysis of Jurkat cells, using anti-PTPN11/SHP2 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/PTPN11-SHP2-Antibody-3F2-Flow-Cytometry-NBP2-03063-img0002.jpg)
![Western Blot: PTPN11/SHP2 Antibody (3F2) [NBP2-03063] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PTPN11/SHP2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PTPN11/SHP2.](http://images.novusbio.com/fullsize/PTPN11-SHP2-Antibody-3F2-Western-Blot-NBP2-03063-img0003.jpg)
![Flow Cytometry: PTPN11/SHP2 Antibody (3F2) [NBP2-03063] - Analysis of Hela cells, using anti-PTPN11/SHP2 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/PTPN11-SHP2-Antibody-3F2-Flow-Cytometry-NBP2-03063-img0001.jpg)
![Western Blot: FAK Antibody (10H7) [NBP2-22168] - Western blot analysis using FAK mouse mAb against A549 (1) and NIH/3T3 (2) cell lysate.](http://images.novusbio.com/fullsize/FAK-Antibody-10H7-Western-Blot-NBP2-22168-img0003.jpg "Western Blot: FAK Antibody (10H7) [NBP2-22168] - Western blot analysis using FAK mouse mAb against A549 (1) and NIH/3T3 (2) cell lysate.")
![Immunocytochemistry/Immunofluorescence: FAK Antibody (10H7) [NBP2-22168] - Immunofluorescence analysis of B16 cells using FAK mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.](http://images.novusbio.com/fullsize/FAK-Antibody-10H7-Immunocytochemistry-Immunofluorescence-NBP2-22168-img0001.jpg)
![Immunohistochemistry-Paraffin: FAK Antibody (10H7) [NBP2-22168] - Immunohistochemical analysis of paraffin-embedded cervices tumour using FAK mouse mAb with DAB staining](http://images.novusbio.com/fullsize/FAK-Antibody-10H7-Immunohistochemistry-Paraffin-NBP2-22168-img0002.jpg)
![Immunohistochemistry-Frozen: Nitrotyrosine Antibody (EM-30) [NBP1-96130] - Human tumoral colon epithelium with anti-nitrotyrosine antibody (EM-30).](http://images.novusbio.com/fullsize/Nitrotyrosine-Antibody-EM-30-Immunohistochemistry-Frozen-NBP1-96130-img0001.jpg "Immunohistochemistry-Frozen: Nitrotyrosine Antibody (EM-30) [NBP1-96130] - Human tumoral colon epithelium with anti-nitrotyrosine antibody (EM-30).")
![Western Blot: AKT1 Antibody (PSH0-50) [NBP3-32016] - Western blot analysis of AKT1 on different lysates with Rabbit anti-AKT1 antibody (NBP3-32016) at 1/1,000 dilution. Lane 1: Jurkat cell lysate Lane 2: MCF7 cell lysate Lane 3: HeLa cell lysate Lane 4: NIH/3T3 cell lysate Lane 5: C2C12 cell lysate Lane 6: COS-1 cell lysate Lane 7: PC-12 cell lysate Lane 8: Mouse brain tissue lysate Lysates/proteins at 30 ug/Lane. Predicted band size: 56 kDa Observed band size: 60 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32016) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32016_rabbit-akt1-mab-psh0-50-27820241514178.jpg "Western Blot: AKT1 Antibody (PSH0-50) [NBP3-32016] - Western blot analysis of AKT1 on different lysates with Rabbit anti-AKT1 antibody (NBP3-32016) at 1/1,000 dilution. Lane 1: Jurkat cell lysate Lane 2: MCF7 cell lysate Lane 3: HeLa cell lysate Lane 4: NIH/3T3 cell lysate Lane 5: C2C12 cell lysate Lane 6: COS-1 cell lysate Lane 7: PC-12 cell lysate Lane 8: Mouse brain tissue lysate Lysates/proteins at 30 ug/Lane. Predicted band size: 56 kDa Observed band size: 60 kDa Exposure time: 3 minutes; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-32016) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:100,000 dilution was used for 1 hour at room temperature.")
![Immunocytochemistry/ Immunofluorescence: AKT1 Antibody (PSH0-50) [NBP3-32016] - Immunocytochemistry analysis of Jurkat cells labeling AKT1 with Rabbit anti-AKT1 antibody (NBP3-32016) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-AKT1 antibody (NBP3-32016) at 1/50 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488) was used as the secondary antibody at 1/1,000 dilution. Nuclear DNA was labelled in blue with DAPI. Beta tubulin (red) was stained at 1/200 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594) was used as the secondary antibody at 1/1,000 dilution.](http://images.novusbio.com/fullsize/nbp3-32016_rabbit-akt1-mab-psh0-50-2920241192386.jpg)
![Flow Cytometry: AKT1 Antibody (PSH0-50) [NBP3-32016] - Flow cytometric analysis of Jurkat cells labeling AKT1. Cells were fixed and permeabilized. Then stained with the primary antibody (NBP3-32016, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).](http://images.novusbio.com/fullsize/nbp3-32016_rabbit-akt1-mab-psh0-50-39202488468.jpg)
![Flow Cytometry: Insulin R/CD220 Antibody (83-14) [NBP2-81038] - Flow-cytometry using the Insulin R/CD220 Antibody (83-14) [NBP2-81038]. Jurkat cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of 83-14 (NBP2-81038, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Insulin-R-CD220-Antibody-83-14-Flow-Cytometry-NBP2-81038-img0001.jpg "Flow Cytometry: Insulin R/CD220 Antibody (83-14) [NBP2-81038] - Flow-cytometry using the Insulin R/CD220 Antibody (83-14) [NBP2-81038]. Jurkat cells were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of 83-14 (NBP2-81038, blue line) at a concentration of 10 ug/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 ug/ml and cells analyzed on a FACSCanto flow-cytometer.")
![Western Blot: EGF R/ErbB1 [p Tyr1197] Antibody [NBP1-77936] - Lane 1: unstimulated A431 cells. Lane 2: A431 cells stimulated with EGF (50 ng/ml for 15 min). Load: 30 ug per lane. Primary antibody: EGFR pY1197 antibody at 1:250 for overnight at 4C. Secondary antibody: IRDye800 (TM) rabbit secondary antibody at 1:10,000 for 45 min at RT. Block: 5% BLOTTO overnight at 4C. Predicted/Observed size: 134.3 kDa, ~170 kDa for EGFR pY1197.](http://images.novusbio.com/fullsize/EGF-R-ErbB1-[p-Tyr1197]-Antibody-Western-Blot-NBP1-77936-img0003.jpg "Western Blot: EGF R/ErbB1 [p Tyr1197] Antibody [NBP1-77936] - Lane 1: unstimulated A431 cells. Lane 2: A431 cells stimulated with EGF (50 ng/ml for 15 min). Load: 30 ug per lane. Primary antibody: EGFR pY1197 antibody at 1:250 for overnight at 4C. Secondary antibody: IRDye800 (TM) rabbit secondary antibody at 1:10,000 for 45 min at RT. Block: 5% BLOTTO overnight at 4C. Predicted/Observed size: 134.3 kDa, ~170 kDa for EGFR pY1197.")
![Immunohistochemistry-Paraffin: EGF R/ErbB1 [p Tyr1197] Antibody [NBP1-77936] - Tissue: placental trophoblasts. Fixation: formalin fixed paraffin embedded. Antigen retrieval: not required. Primary antibody: EGFR pY1197 antibody at 5ug/mL for 1 h at RT. Secondary antibody: Peroxidase rabbit secondary antibody at 1:10,000 for 45 min at RT. Localization: EGFR pY1197 is on the cell membrane. Staining: EGFR pY1197 as precipitated red signal with hematoxylin purple counterstain.](http://images.novusbio.com/fullsize/EGF-R-ErbB1-[p-Tyr1197]-Antibody-Immunohistochemistry-Paraffin-NBP1-77936-img0002.jpg)
![Immunohistochemistry-Paraffin: S100A9 Antibody (S100A9/1075) [NBP2-44913] - Formalin-fixed, paraffin-embedded human skin carcinoma stained with S100A9 Antibody (S100A9/1075).](http://images.novusbio.com/fullsize/S100A9-Antibody-S100A9-1075-Immunohistochemistry-Paraffin-NBP2-44913-img0002.jpg "Immunohistochemistry-Paraffin: S100A9 Antibody (S100A9/1075) [NBP2-44913] - Formalin-fixed, paraffin-embedded human skin carcinoma stained with S100A9 Antibody (S100A9/1075).")
![Immunohistochemistry-Paraffin: S100A9 Antibody (S100A9/1075) [NBP2-44913] - Formalin-fixed, paraffin-embedded human breast carcinoma stained with S100A9 Antibody (S100A9/1075).](http://images.novusbio.com/fullsize/S100A9-Antibody-S100A9-1075-Immunohistochemistry-Paraffin-NBP2-44913-img0001.jpg)
![Western Blot: EGFR [p Tyr1148] Antibody [NBP3-13231] - Untreated (-) and treated (+) A431 whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with EGFR (phospho Tyr1148) antibody (NBP3-13231) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/EGFR-[p-Tyr1148]-Antibody-Western-Blot-NBP3-13231-img0001.jpg "<b>Biological Strategies Validation. </b>Western Blot: EGFR [p Tyr1148] Antibody [NBP3-13231] - Untreated (-) and treated (+) A431 whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with EGFR (phospho Tyr1148) antibody (NBP3-13231) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: EGFR [p Tyr1148] Antibody [NBP3-13231] - EGFR (phospho Tyr1148) antibody detects EGFR (phospho Tyr1148) protein at cell membrane by immunofluorescent analysis. Sample: A431 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: EGFR (phospho Tyr1148) protein stained by EGFR (phospho Tyr1148) antibody (NBP3-13231) diluted at 1:500. Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/EGFR-[p-Tyr1148]-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-13231-img0002.jpg)
![Immunohistochemistry-Paraffin: EGFR [p Tyr1148] Antibody [NBP3-13231] - EGFR (phospho Tyr1148) antibody detects EGFR protein at cell membrane in human breast carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded human breast carcinoma. EGFR (phospho Tyr1148) antibody (NBP3-13231) diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/EGFR-[p-Tyr1148]-Antibody-Immunohistochemistry-Paraffin-NBP3-13231-img0003.jpg)